Skip to main content
CIZZLE BIOTECHNOLOGY HOLDINGS PLC logo

CIZZLE BIOTECHNOLOGY HOLDINGS PLC — Investor Relations & Filings

Ticker · CIZ ISIN · GB00BNG2VN02 LEI · 213800G3OS3SA2J1Y358 IL Professional, scientific and technical activities
Open in API
Filings indexed 305 across all filing types
Latest filing 2023-08-15 M&A Activity
Country GB United Kingdom
Listing IL CIZ

About CIZZLE BIOTECHNOLOGY HOLDINGS PLC

https://cizzlebiotechnology.com/

Cizzle Biotechnology Holdings PLC is a cancer diagnostics developer focused on the early detection of lung cancer. The company is advancing a non-invasive, cost-effective blood test designed to identify lung cancer at its earliest stages, often before symptoms appear. The test utilizes a proprietary CIZ1B biomarker and an advanced immunoassay. Its primary goal is to improve patient outcomes by enabling swift, curative medical intervention. The technology aims to streamline the diagnostic pathway, reduce reliance on CT scans which can have high false-positive rates, and eliminate unnecessary invasive follow-up procedures. The company, a spin-out from the University of York, is conducting clinical trials to support global regulatory approval and adoption of its technology.

Recent filings

Filing Released Lang Actions
Update on Put Option with Conduit
M&A Activity Classification · 1% confidence The document is identified by the RNS Number header and contains a date stamp typical of regulatory news services. The content provides an 'Update on Put Option' involving a business combination agreement (Conduit-Murphy Transaction) and references SEC filings (Form S-4, notice of effectiveness). Crucially, the document ends with standard boilerplate text from 'RNS, the news service of the London Stock Exchange,' stating that 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure strongly indicates a general regulatory announcement disseminated via the RNS system, which aligns best with the 'Regulatory Filings' category, as it is not a specific financial report (10-K, IR, ER) or a specific corporate action announcement like a dividend or director dealing.
2023-08-15 English
Expansion of Research Agreement and CIZ1B Update
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated August 10, 2023. It announces an 'Expansion of Research Agreement' and 'Update on Progress' regarding a cancer diagnosis test. The content details scientific progress, expansion of R&D, and future regulatory steps (FDA, EMA, MHRA). The footer explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure and source identification strongly indicate a general regulatory announcement disseminated via the RNS system, which corresponds to the 'Regulatory Filings' category (RNS), as it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action announcement (like DIV, CAP, DIRS).
2023-08-10 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number: 5834E) from Cizzle Biotechnology Holdings PLC, dated 30 June 2023. The core content is titled 'Total Voting Rights' and explicitly states the company's issued share capital and total number of voting rights as required by the FCA's Disclosure Guidance and Transparency Rules (Rule 5.6.1). This type of mandatory disclosure regarding the total number of shares and voting rights, often released when there is a change or as a routine update, fits best under the general regulatory announcement category. Since it is not a specific financial report (like 10-K or IR), a management change (MANG), or a director's trade (DIRS), the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for mandatory regulatory updates not covered elsewhere.
2023-06-30 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states 'Result of AGM' and details the voting outcomes for various resolutions presented at the Annual General Meeting ('AGM'). Resolution 1 specifically mentions receiving the 'Company's annual report and accounts', confirming the context is the AGM proceedings. This directly maps to the AGM Information category.
2023-06-28 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the header "RNS Number : 4385C" and contains the standard footer information for RNS (Regulatory News Service) announcements from the London Stock Exchange. The content explicitly discusses a 'correction to the total voting rights figure' following a share admission, stating the new total number of Ordinary Shares in issue (363,841,773). This type of announcement, dealing with the total number of shares and voting rights, is a specific regulatory disclosure. While it relates to capital structure, the primary function here is the formal notification of the updated voting rights denominator, which is often categorized under general regulatory announcements or specific voting rights disclosures. Given the options, this is a formal regulatory announcement disseminated via RNS. Since there is no specific code for 'Total Voting Rights Correction', and it is a mandatory regulatory disclosure, it fits best under the general 'Regulatory Filings' (RNS) category, as it is not a full financial report (10-K, IR), a dividend notice (DIV), or a management change (MANG). It is also not a Declaration of Voting Results (DVA), which pertains to the outcome of a vote, but rather the mechanics of voting rights.
2023-06-12 English
Subscription to raise £350,000
Share Issue/Capital Change Classification · 1% confidence The document is clearly identified as an RNS announcement (RNS Number : 3252C) from Cizzle Biotechnology Holdings PLC, dated 12 June 2023. The content details a capital-raising event: a Subscription to raise £350,000 and a variation to a Loan Facility. This involves the issuance of new Ordinary Shares and discusses admission to the London Stock Exchange. This falls under the category of financing activities and capital structure changes. The most appropriate specific code is 'CAP' (Capital/Financing Update). Although it is distributed via RNS, the core subject matter is a capital raise, making CAP more specific than the general 'RNS' fallback.
2023-06-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.